Tags

Type your tag names separated by a space and hit enter

IL-1- and TNF-induced bone resorption is mediated by p38 mitogen activated protein kinase.
J Cell Physiol 2001; 187(3):294-303JC

Abstract

We have previously shown that p38 mitogen-activated protein kinase (MAPK) inhibitors, which block the production and action of inflammatory cytokines such as tumor necrosis factor (TNF) and interleukin-1 (IL-1), are effective in models of bone and cartilage degradation. To further investigate the role of p38 MAPK, we have studied its activation in osteoblasts and chondrocytes, following treatment with a panel of proinflammatory and osteotropic agents. In osteoblasts, significant activation of p38 MAPK was observed following treatment with IL-1 and TNF, but not parathyroid hormone, transforming growth factor-beta (TGF-beta), 1,25(OH)(2)D(3), insulin-like growth factor-1 (IGF-1), or IGF-II. Similar results were obtained using primary bovine chondrocytes and an SV40-immortalized human chondrocyte cell line, T/C28A4. SB 203580, a selective inhibitor of p38 MAPK, inhibited IL-1 and TNF-induced p38 MAPK activity and IL-6 production (IC(50)s 0.3--0.5 microM) in osteoblasts and chondrocytes. In addition, IL-1 and TNF also activated p38 MAPK in fetal rat long bones and p38 MAPK inhibitors inhibited IL-1- and TNF-stimulated bone resorption in vitro in a dose-dependent manner (IC(50)s 0.3--1 microM). These data support the contention that p38 MAPK plays a central role in regulating the production of, and responsiveness to, proinflammatory cytokines in bone and cartilage. Furthermore, the strong correlation between inhibition of kinase activity and IL-1 and TNF-stimulated biological responses indicates that selective inhibition of the p38 MAPK pathway may have therapeutic utility in joint diseases such as rheumatoid arthritis (RA).

Authors+Show Affiliations

Department of Musculoskeletal Diseases, Glaxo SmithKline, King of Prussia, Pennsylvania, USA. Sanjay_Kumar@SBPHRD.COMNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

11319753

Citation

Kumar, S, et al. "IL-1- and TNF-induced Bone Resorption Is Mediated By P38 Mitogen Activated Protein Kinase." Journal of Cellular Physiology, vol. 187, no. 3, 2001, pp. 294-303.
Kumar S, Votta BJ, Rieman DJ, et al. IL-1- and TNF-induced bone resorption is mediated by p38 mitogen activated protein kinase. J Cell Physiol. 2001;187(3):294-303.
Kumar, S., Votta, B. J., Rieman, D. J., Badger, A. M., Gowen, M., & Lee, J. C. (2001). IL-1- and TNF-induced bone resorption is mediated by p38 mitogen activated protein kinase. Journal of Cellular Physiology, 187(3), pp. 294-303.
Kumar S, et al. IL-1- and TNF-induced Bone Resorption Is Mediated By P38 Mitogen Activated Protein Kinase. J Cell Physiol. 2001;187(3):294-303. PubMed PMID: 11319753.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - IL-1- and TNF-induced bone resorption is mediated by p38 mitogen activated protein kinase. AU - Kumar,S, AU - Votta,B J, AU - Rieman,D J, AU - Badger,A M, AU - Gowen,M, AU - Lee,J C, PY - 2001/4/25/pubmed PY - 2001/5/25/medline PY - 2001/4/25/entrez SP - 294 EP - 303 JF - Journal of cellular physiology JO - J. Cell. Physiol. VL - 187 IS - 3 N2 - We have previously shown that p38 mitogen-activated protein kinase (MAPK) inhibitors, which block the production and action of inflammatory cytokines such as tumor necrosis factor (TNF) and interleukin-1 (IL-1), are effective in models of bone and cartilage degradation. To further investigate the role of p38 MAPK, we have studied its activation in osteoblasts and chondrocytes, following treatment with a panel of proinflammatory and osteotropic agents. In osteoblasts, significant activation of p38 MAPK was observed following treatment with IL-1 and TNF, but not parathyroid hormone, transforming growth factor-beta (TGF-beta), 1,25(OH)(2)D(3), insulin-like growth factor-1 (IGF-1), or IGF-II. Similar results were obtained using primary bovine chondrocytes and an SV40-immortalized human chondrocyte cell line, T/C28A4. SB 203580, a selective inhibitor of p38 MAPK, inhibited IL-1 and TNF-induced p38 MAPK activity and IL-6 production (IC(50)s 0.3--0.5 microM) in osteoblasts and chondrocytes. In addition, IL-1 and TNF also activated p38 MAPK in fetal rat long bones and p38 MAPK inhibitors inhibited IL-1- and TNF-stimulated bone resorption in vitro in a dose-dependent manner (IC(50)s 0.3--1 microM). These data support the contention that p38 MAPK plays a central role in regulating the production of, and responsiveness to, proinflammatory cytokines in bone and cartilage. Furthermore, the strong correlation between inhibition of kinase activity and IL-1 and TNF-stimulated biological responses indicates that selective inhibition of the p38 MAPK pathway may have therapeutic utility in joint diseases such as rheumatoid arthritis (RA). SN - 0021-9541 UR - https://www.unboundmedicine.com/medline/citation/11319753/IL_1__and_TNF_induced_bone_resorption_is_mediated_by_p38_mitogen_activated_protein_kinase_ L2 - https://doi.org/10.1002/jcp.1082 DB - PRIME DP - Unbound Medicine ER -